Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

Schuurhuizen CSEW, Braamse AMJ, Beekman ATF, Cuijpers P, van der Linden MHM, Hoogendoorn AW, Berkhof H, Sommeijer DW, Lustig V, Vrijaldenhoven S, Bloemendal HJ, van Groeningen CJ, van Zweeden AA, van der Vorst MJDL, Rietbroek R, Tromp-van Driel CS, Wymenga MNW, van der Linden PW, Beeker A, Polee MB, Batman E, Los M, van Bochove A, Brakenhoff JAC, Konings IRHM, Verheul HMW, Dekker J.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):911-920. doi: 10.6004/jnccn.2019.7285.

PMID:
31390590
2.

Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study.

Menning S, de Ruiter MB, Kieffer JM, Agelink van Rentergem J, Veltman DJ, Fruijtier A, Oldenburg HS, Boven E, van der Meij S, Lustig V, Bos ME, Boogerd W, Reneman L, Schagen SB.

J Pain Symptom Manage. 2016 Oct;52(4):560-569.e1. doi: 10.1016/j.jpainsymman.2016.04.012. Epub 2016 Sep 17.

PMID:
27650011
3.

Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial.

van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK.

J Clin Oncol. 2015 Jun 10;33(17):1918-27. doi: 10.1200/JCO.2014.59.1081. Epub 2015 Apr 27.

PMID:
25918291
4.

Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?

Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS.

Clin Chem. 2008 Apr;54(4):747-51. doi: 10.1373/clinchem.2007.094664.

5.

Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?

Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS.

Clin Biochem. 2008 Apr;41(6):436-9. doi: 10.1016/j.clinbiochem.2007.12.010. Epub 2007 Dec 27.

6.

"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, Macrae AR, Jaffe AS.

Clin Chim Acta. 2008 Jan;387(1-2):133-8. Epub 2007 Oct 3.

7.

Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.

Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS.

Clin Chem. 2007 Dec;53(12):2112-8. Epub 2007 Oct 11.

8.

Authors' response to Apple editorial.

Kavsak PA, MacRae AR, Lustig V, Newman AM, Ko DT, Tu JV, Palomaki GE, Jaffe AS.

Clin Chim Acta. 2007 May 1;380(1-2):245-6. Epub 2007 Jan 23. No abstract available.

PMID:
17328878
9.

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.

Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS.

Clin Chim Acta. 2007 May 1;380(1-2):213-6. Epub 2007 Jan 23.

PMID:
17306781
10.

Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.

Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS.

Clin Biochem. 2007 Mar;40(5-6):326-9. Epub 2007 Jan 5.

PMID:
17292342
11.

Long-term health outcomes associated with detectable troponin I concentrations.

Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS.

Clin Chem. 2007 Feb;53(2):220-7. Epub 2007 Jan 4.

12.

Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients.

Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS.

Clin Chem. 2006 Nov;52(11):2028-35. Epub 2006 Sep 21.

13.

The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.

Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS.

Am Heart J. 2006 Jul;152(1):118-25.

PMID:
16824840
14.

Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.

Macrae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS.

Clin Chem. 2006 May;52(5):812-8. Epub 2006 Mar 23.

15.

Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands.

Kruijtzer CMF, Verweij J, Schellens JH, Beijnen JH, Pronk L, Bo M, Lustig V, van Tinteren H, Mackay M, Ten Bokkel Huinink WW.

Anticancer Drugs. 2000 Apr;11(4):249-55.

PMID:
10898539
16.

Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion.

Rosing H, Lustig V, van Warmerdam LJ, Huizing MT, ten Bokkel Huinink WW, Schellens JH, Rodenhuis S, Bult A, Beijnen JH.

Cancer Chemother Pharmacol. 2000;45(3):213-8.

PMID:
10663639
17.

Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction.

Rosing H, Lustig V, Koopman FP, ten Bokkel Huinink WW, Beijnen JH.

J Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):89-98.

PMID:
9300913
18.

Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients.

ten Bokkel Huinink WW, Lustig V, Dubbelman R, Hiemstra A, Rodenhuis S.

Eur J Cancer. 1997 Aug;33 Suppl 7:S23-5.

PMID:
9486100
20.

Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW.

J Urol. 1993 Mar;149(3):492-7.

PMID:
8437253
21.

Squamous cell carcinoma of the penis. II. Treatment of the primary tumor.

Horenblas S, van Tinteren H, Delemarre JF, Boon TA, Moonen LM, Lustig V.

J Urol. 1992 Jun;147(6):1533-8.

PMID:
1593683
22.
23.

Intracardiac metastases, report of three cases.

Lustig V, Vlasveld LT, Bakker RH, Schreuder JE, Mooi WJ, ten Bokkel Huinink WW.

Neth J Med. 1991 Feb;38(1-2):29-32.

PMID:
2030806
24.

Time-resolved immunofluorometric assay of human pancreatic isoamylase in serum, with use of two monoclonal antibodies.

Diamandis EP, Papanastasiou-Diamandi A, Lustig V, Khosravi MJ, Tan A.

Clin Chem. 1989 Sep;35(9):1915-20.

27.

Comments on an evaluation of a kit for the determination of calcium in serum and urine.

Lustig V.

Clin Chem. 1984 Aug;30(8):1417-8. No abstract available.

PMID:
6744604
29.

Elimination of pyruvate interference in the enzymic determination of amylase.

Lustig V.

Clin Chem. 1980 Mar;26(3):527-9. No abstract available.

PMID:
6153945
30.

Improved serum initiated aspartate aminotransferase assay by inhibition of lactate dehydrogenase with oxamate.

Lustig V, Redman LW.

Clin Biochem. 1979 Dec;12(6):254-5. No abstract available.

PMID:
535158
31.
32.

Activation of aspartate transaminase by pyridoxal 5'-phosphate in the serum of normal subjects.

Lustig V, Patten R.

Clin Chim Acta. 1976 May 17;69(1):101-3. No abstract available.

PMID:
1269145
33.
34.

Fructose-1,6-diphosphatase in DMBA-induced rat mammary tumours.

Lustig V, Kellen JA.

Oncology. 1973;27(3):266-80. No abstract available.

PMID:
4350140
35.

Fructose 1,6-diphosphatase activity in rat mammary glands.

Lustig V, Kellen JA.

Comp Biochem Physiol B. 1972 Aug 15;42(4):703-11. No abstract available.

PMID:
4342455
36.

Effects of L-homoarginine on rat tissue alkaline phosphatases in vivo.

Lustig V, Kellen JA.

Enzymologia. 1971 Dec 31;41(6):336-44. No abstract available.

PMID:
5136202
37.

Temperature optimum of alkaline phosphatases in some homeothermic and poikilothermic species.

Lustig V, Kellen JA.

Comp Biochem Physiol B. 1971 Jun 15;39(2):311-5. No abstract available.

PMID:
5000930
38.

The ultrastructural localization of alkaline phosphatase isoenzymes in some normal and malignant cells.

Lustig V, Kellen JA.

Enzyme. 1971;12(1):76-87. No abstract available.

PMID:
5560402
39.

Patterns of amino-acid inhibition of alkaline phosphatases as an aid in cancer diagnosis.

Kellen JA, Lustig V.

Oncology. 1971;25(3):239-48. No abstract available.

PMID:
5153085

Supplemental Content

Loading ...
Support Center